Tandem Diabetes Care (TNDM) Other Non Operating Income (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Other Non Operating Income came in at $1.7 million in Q1 2026, up 113.16% on a QoQ basis from -$12.9 million in Q4 2025.
Tandem Diabetes Care (TNDM) Other Non Operating Income (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Other Non Operating Income data on file, last reported at $1.7 million in Q1 2026.
- Quarterly Other Non Operating Income changed N/A year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.8 million (down 349.57% YoY) and the FY2025 annual result came in at -$13.0 million, changed N/A from the prior year.
- Other Non Operating Income advanced to $1.7 million in Q1 2026, from -$12.9 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $4.2 million in Q2 2023 to a low of -$12.9 million in Q4 2025.
- A 5-year average of $291538.5 and a median of $1.3 million in 2024 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income soared 687.76% — and 2025, when it sank 1120.27%.
- Tracing TNDM's Other Non Operating Income over 5 years: stood at $1.7 million in 2022, then surged by 125.36% to $3.8 million in 2023, then slumped by 66.19% to $1.3 million in 2024, then slumped by 1120.27% to -$12.9 million in 2025, then soared by 113.16% to $1.7 million in 2026.
- The last three Other Non Operating Income figures came in at $1.7 million (Q1 2026), -$12.9 million (Q4 2025), and -$612000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.11 Bn | 144.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.87 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | -12.94 Mn |
| Jun 30, 2025 | -612,000.00 |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 3.48 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 3.75 Mn |
| Sep 30, 2023 | 816,000.00 |
| Jun 30, 2023 | 4.18 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | 144,000.00 |
| Jun 30, 2022 | -711,000.00 |
| Mar 31, 2022 | -1.10 Mn |
| Dec 31, 2021 | -1.59 Mn |
| Sep 30, 2021 | -1.87 Mn |
| Jun 30, 2021 | -1.36 Mn |
| Mar 31, 2021 | -1.92 Mn |
| Dec 31, 2020 | -1.62 Mn |
| Sep 30, 2020 | -8.36 Mn |